
Obafemi Oludayo Sosanya
Examiner (ID: 19368, Phone: (571)270-1069 , Office: P/2486 )
| Most Active Art Unit | 2486 |
| Art Unit(s) | 2486, 2423 |
| Total Applications | 511 |
| Issued Applications | 376 |
| Pending Applications | 0 |
| Abandoned Applications | 137 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18877543
[patent_doc_number] => 20240000912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES
[patent_app_type] => utility
[patent_app_number] => 18/034239
[patent_app_country] => US
[patent_app_date] => 2021-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59890
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18034239
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/034239 | IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES | Oct 31, 2021 | Pending |
Array
(
[id] => 20453039
[patent_doc_number] => 12516089
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-06
[patent_title] => Bacteria based protein delivery
[patent_app_type] => utility
[patent_app_number] => 18/249626
[patent_app_country] => US
[patent_app_date] => 2021-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 37897
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 302
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18249626
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/249626 | Bacteria based protein delivery | Oct 25, 2021 | Issued |
Array
(
[id] => 20453039
[patent_doc_number] => 12516089
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-06
[patent_title] => Bacteria based protein delivery
[patent_app_type] => utility
[patent_app_number] => 18/249626
[patent_app_country] => US
[patent_app_date] => 2021-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 37897
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 302
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18249626
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/249626 | Bacteria based protein delivery | Oct 25, 2021 | Issued |
Array
(
[id] => 18771170
[patent_doc_number] => 20230365982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => STANDARDISED CYANOBACTERIAL STRAIN ENGINEERING
[patent_app_type] => utility
[patent_app_number] => 18/246564
[patent_app_country] => US
[patent_app_date] => 2021-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8785
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18246564
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/246564 | STANDARDISED CYANOBACTERIAL STRAIN ENGINEERING | Sep 23, 2021 | Pending |
Array
(
[id] => 18895227
[patent_doc_number] => 20240010712
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => ANTIBODIES AGAINST STREPTOCOCCAL M PROTEIN
[patent_app_type] => utility
[patent_app_number] => 18/245884
[patent_app_country] => US
[patent_app_date] => 2021-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16087
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18245884
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/245884 | ANTIBODIES AGAINST STREPTOCOCCAL M PROTEIN | Sep 19, 2021 | Pending |
Array
(
[id] => 18647827
[patent_doc_number] => 20230293602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => COMBINATION IMMUNOTHERAPY METHODS FOR THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 18/042231
[patent_app_country] => US
[patent_app_date] => 2021-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21957
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18042231
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/042231 | COMBINATION IMMUNOTHERAPY METHODS FOR THE TREATMENT OF CANCER | Aug 19, 2021 | Pending |
Array
(
[id] => 18610874
[patent_doc_number] => 20230277604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => THERAPEUTIC AGENT OR DIAGNOSTIC AGENT FOR CANCER
[patent_app_type] => utility
[patent_app_number] => 18/017934
[patent_app_country] => US
[patent_app_date] => 2021-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6700
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18017934
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/017934 | THERAPEUTIC AGENT OR DIAGNOSTIC AGENT FOR CANCER | Jul 26, 2021 | Pending |
Array
(
[id] => 18420460
[patent_doc_number] => 20230174922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => MODIFIED YEAST HOST CELLS USEFUL FOR PRODUCING ISOPRENOL
[patent_app_type] => utility
[patent_app_number] => 18/014004
[patent_app_country] => US
[patent_app_date] => 2021-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17326
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18014004
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/014004 | MODIFIED YEAST HOST CELLS USEFUL FOR PRODUCING ISOPRENOL | Jul 6, 2021 | Pending |
Array
(
[id] => 18724375
[patent_doc_number] => 20230338519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => FUSION PROTEIN WITH IMMUNOENHANCING ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 17/998693
[patent_app_country] => US
[patent_app_date] => 2021-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22645
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -45
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17998693
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/998693 | FUSION PROTEIN WITH IMMUNOENHANCING ACTIVITY | May 13, 2021 | Pending |
Array
(
[id] => 18057979
[patent_doc_number] => 20220389065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => ANTICANCER COMPOSITION COMPRISING TLR5 AGONIST DERIVED FROM FLAGELLIN AS ACTIVE INGREDIENT
[patent_app_type] => utility
[patent_app_number] => 17/789300
[patent_app_country] => US
[patent_app_date] => 2021-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5072
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17789300
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/789300 | ANTICANCER COMPOSITION COMPRISING TLR5 AGONIST DERIVED FROM FLAGELLIN AS ACTIVE INGREDIENT | May 6, 2021 | Pending |
Array
(
[id] => 18057979
[patent_doc_number] => 20220389065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => ANTICANCER COMPOSITION COMPRISING TLR5 AGONIST DERIVED FROM FLAGELLIN AS ACTIVE INGREDIENT
[patent_app_type] => utility
[patent_app_number] => 17/789300
[patent_app_country] => US
[patent_app_date] => 2021-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5072
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17789300
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/789300 | ANTICANCER COMPOSITION COMPRISING TLR5 AGONIST DERIVED FROM FLAGELLIN AS ACTIVE INGREDIENT | May 6, 2021 | Pending |
Array
(
[id] => 18829686
[patent_doc_number] => 20230398210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => IMPROVEMENTS IN VACCINE FORMULATIONS FOR MEDICAL USE
[patent_app_type] => utility
[patent_app_number] => 17/917010
[patent_app_country] => US
[patent_app_date] => 2021-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11284
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17917010
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/917010 | IMPROVEMENTS IN VACCINE FORMULATIONS FOR MEDICAL USE | Apr 8, 2021 | Pending |
Array
(
[id] => 18829686
[patent_doc_number] => 20230398210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => IMPROVEMENTS IN VACCINE FORMULATIONS FOR MEDICAL USE
[patent_app_type] => utility
[patent_app_number] => 17/917010
[patent_app_country] => US
[patent_app_date] => 2021-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11284
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17917010
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/917010 | IMPROVEMENTS IN VACCINE FORMULATIONS FOR MEDICAL USE | Apr 8, 2021 | Pending |
Array
(
[id] => 18497661
[patent_doc_number] => 20230220326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => VARIANT OF GENUS YARROWIA AND METHOD OF PREPARING FAT USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/796565
[patent_app_country] => US
[patent_app_date] => 2021-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12944
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17796565
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/796565 | VARIANT OF GENUS YARROWIA AND METHOD OF PREPARING FAT USING THE SAME | Mar 4, 2021 | Pending |
Array
(
[id] => 18497661
[patent_doc_number] => 20230220326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => VARIANT OF GENUS YARROWIA AND METHOD OF PREPARING FAT USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/796565
[patent_app_country] => US
[patent_app_date] => 2021-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12944
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17796565
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/796565 | VARIANT OF GENUS YARROWIA AND METHOD OF PREPARING FAT USING THE SAME | Mar 4, 2021 | Pending |
Array
(
[id] => 18325303
[patent_doc_number] => 20230123431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => METABOLIC ENGINEERING FOR PRODUCTION OF LIPOIC ACID
[patent_app_type] => utility
[patent_app_number] => 17/905592
[patent_app_country] => US
[patent_app_date] => 2021-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11479
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17905592
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/905592 | METABOLIC ENGINEERING FOR PRODUCTION OF LIPOIC ACID | Mar 1, 2021 | Pending |
Array
(
[id] => 18257260
[patent_doc_number] => 20230084300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => PREVENTION AND TREATMENT OF INFECTIONS INCLUDING THOSE CAUSED BY CORONAVIRUS
[patent_app_type] => utility
[patent_app_number] => 17/904155
[patent_app_country] => US
[patent_app_date] => 2021-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15951
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17904155
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/904155 | PREVENTION AND TREATMENT OF INFECTIONS INCLUDING THOSE CAUSED BY CORONAVIRUS | Feb 11, 2021 | Pending |
Array
(
[id] => 18312656
[patent_doc_number] => 20230116556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => INCREASED ETHANOL PRODUCTION BY OVEREXPRESSION OF JID1 IN YEAST
[patent_app_type] => utility
[patent_app_number] => 17/794744
[patent_app_country] => US
[patent_app_date] => 2021-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6311
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17794744
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/794744 | INCREASED ETHANOL PRODUCTION BY OVEREXPRESSION OF JID1 IN YEAST | Jan 21, 2021 | Pending |
Array
(
[id] => 18244100
[patent_doc_number] => 20230076411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => LASSO PEPTIDES FOR TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/790103
[patent_app_country] => US
[patent_app_date] => 2021-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49096
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -56
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17790103
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/790103 | LASSO PEPTIDES FOR TREATMENT OF CANCER | Jan 4, 2021 | Pending |
Array
(
[id] => 18208214
[patent_doc_number] => 20230054472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => SAMPLE PREPARATION AND MICROBIAL ANALYSIS
[patent_app_type] => utility
[patent_app_number] => 17/788137
[patent_app_country] => US
[patent_app_date] => 2020-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14929
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -56
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17788137
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/788137 | SAMPLE PREPARATION AND MICROBIAL ANALYSIS | Dec 22, 2020 | Abandoned |